Ankit Sharma1,2, Anne M Durkan3,4,5. 1. Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. 2. University of Sydney, Sydney, Australia. 3. Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. anne.durkan@health.nsw.gov.au. 4. University of Sydney, Sydney, Australia. anne.durkan@health.nsw.gov.au. 5. Department of Nephrology, Locked Bag 4001, Westmead, NSW, 2145, Australia. anne.durkan@health.nsw.gov.au.
Abstract
BACKGROUND: Transplantation is the preferred modality for renal replacement therapy in children. With increasing rates of re-transplantation within the paediatric population, there are more sensitised children on waiting lists. One issue with developing strategies to treat these children is the number of different definitions of sensitisation. and we would therefore recommend an immunological risk stratification approach. METHODS: We discuss methods of sensitisation prevention, assessment and management, including paired exchange programmes and desensitisation protocols. RESULTS: There are limited published evidence-based data for desensitisation in adults and none in children; thus, we present information on the available therapies currently in use. DISCUSSION: Further research is required to investigate strategies which prevent sensitisation in children, including the healthcare utility of incorporating epitope-based matching into organ allocation algorithms. Controlled studies are also needed to establish the most appropriate desensitisation regimen(s).
BACKGROUND: Transplantation is the preferred modality for renal replacement therapy in children. With increasing rates of re-transplantation within the paediatric population, there are more sensitised children on waiting lists. One issue with developing strategies to treat these children is the number of different definitions of sensitisation. and we would therefore recommend an immunological risk stratification approach. METHODS: We discuss methods of sensitisation prevention, assessment and management, including paired exchange programmes and desensitisation protocols. RESULTS: There are limited published evidence-based data for desensitisation in adults and none in children; thus, we present information on the available therapies currently in use. DISCUSSION: Further research is required to investigate strategies which prevent sensitisation in children, including the healthcare utility of incorporating epitope-based matching into organ allocation algorithms. Controlled studies are also needed to establish the most appropriate desensitisation regimen(s).
Authors: A R Tambur; N D Herrera; K M K Haarberg; M F Cusick; R A Gordon; J R Leventhal; J J Friedewald; D Glotz Journal: Am J Transplant Date: 2015-04-30 Impact factor: 8.086
Authors: M Toyoda; D Thomas; G Ahn; J Kahwaji; J Mirocha; M Chu; A Vo; E Suviolahti; S Ge; S C Jordan Journal: Transpl Infect Dis Date: 2015-12 Impact factor: 2.228
Authors: A Hart; J M Smith; M A Skeans; S K Gustafson; D E Stewart; W S Cherikh; J L Wainright; A Kucheryavaya; M Woodbury; J J Snyder; B L Kasiske; A K Israni Journal: Am J Transplant Date: 2017-01 Impact factor: 8.086
Authors: Frans H J Claas; Marian D Witvliet; René J Duquesnoy; Guido G Persijn; Ilias I N Doxiadis Journal: Transplantation Date: 2004-07-27 Impact factor: 4.939
Authors: Ashley A Vo; Marina Lukovsky; Mieko Toyoda; Jennifer Wang; Nancy L Reinsmoen; Chih-Hung Lai; Alice Peng; Rafael Villicana; Stanley C Jordan Journal: N Engl J Med Date: 2008-07-17 Impact factor: 91.245
Authors: Anna M Adamusiak; Jelena Stojanovic; Olivia Shaw; Robert Vaughan; Neil J Sebire; Martin Drage; Nicos Kessaris; Stephen D Marks; Nizam Mamode Journal: Pediatr Nephrol Date: 2016-09-01 Impact factor: 3.714